Weight loss on GLP-1 medications varies a lot from person to person, but most people see meaningful, steady progress over many months rather than quick drops.
Clinical trials of Semaglutide (Wegovy) showed average weight loss of around 15% of starting body weight over 68 weeks, while Tirzepatide (Zepbound) trials showed averages closer to 18-22% over a similar timeframe, depending on dose. Many people lose faster in the first 4 to 8 weeks as appetite suppression kicks in and water weight shifts, then settle into a more typical pace of about 1 to 2 pounds per week. Some weeks you will lose nothing, then suddenly drop a few pounds. These stalls are normal and do not mean the medication has stopped working.
Several things influence your personal rate:
Plateaus around the 3 to 6 month mark are commonly reported and often resolve with a dose increase, dietary tweaks, or simply more time. It is worth tracking weekly averages rather than daily numbers, since the scale fluctuates with hydration and hormones.
If your progress feels much slower than expected, talk to your provider about whether a dose adjustment or a switch to a different GLP-1 might help. Patience matters here. These are tools that work alongside lifestyle changes, not overnight solutions, and the slow-and-steady losers tend to have the best long-term outcomes.
Different ways people phrase this question. Each expands to the same answer.
Weight loss on GLP-1 medications varies a lot from person to person, but most people see meaningful, steady progress over many months rather than quick drops.
Clinical trials of Semaglutide (Wegovy) showed average weight loss of around 15% of starting body weight over 68 weeks, while Tirzepatide (Zepbound) trials showed averages closer to 18-22% over a similar timeframe, depending on dose. Many people lose faster in the first 4 to 8 weeks as appetite suppression kicks in and water weight shifts, then settle into a more typical pace of about 1 to 2 pounds per week. Some weeks you will lose nothing, then suddenly drop a few pounds. These stalls are normal and do not mean the medication has stopped working.
Several things influence your personal rate:
Plateaus around the 3 to 6 month mark are commonly reported and often resolve with a dose increase, dietary tweaks, or simply more time. It is worth tracking weekly averages rather than daily numbers, since the scale fluctuates with hydration and hormones.
If your progress feels much slower than expected, talk to your provider about whether a dose adjustment or a switch to a different GLP-1 might help. Patience matters here. These are tools that work alongside lifestyle changes, not overnight solutions, and the slow-and-steady losers tend to have the best long-term outcomes.
Weight loss on GLP-1 medications varies a lot from person to person, but most people see meaningful, steady progress over many months rather than quick drops.
Clinical trials of Semaglutide (Wegovy) showed average weight loss of around 15% of starting body weight over 68 weeks, while Tirzepatide (Zepbound) trials showed averages closer to 18-22% over a similar timeframe, depending on dose. Many people lose faster in the first 4 to 8 weeks as appetite suppression kicks in and water weight shifts, then settle into a more typical pace of about 1 to 2 pounds per week. Some weeks you will lose nothing, then suddenly drop a few pounds. These stalls are normal and do not mean the medication has stopped working.
Several things influence your personal rate:
Plateaus around the 3 to 6 month mark are commonly reported and often resolve with a dose increase, dietary tweaks, or simply more time. It is worth tracking weekly averages rather than daily numbers, since the scale fluctuates with hydration and hormones.
If your progress feels much slower than expected, talk to your provider about whether a dose adjustment or a switch to a different GLP-1 might help. Patience matters here. These are tools that work alongside lifestyle changes, not overnight solutions, and the slow-and-steady losers tend to have the best long-term outcomes.
Weight loss on GLP-1 medications varies a lot from person to person, but most people see meaningful, steady progress over many months rather than quick drops.
Clinical trials of Semaglutide (Wegovy) showed average weight loss of around 15% of starting body weight over 68 weeks, while Tirzepatide (Zepbound) trials showed averages closer to 18-22% over a similar timeframe, depending on dose. Many people lose faster in the first 4 to 8 weeks as appetite suppression kicks in and water weight shifts, then settle into a more typical pace of about 1 to 2 pounds per week. Some weeks you will lose nothing, then suddenly drop a few pounds. These stalls are normal and do not mean the medication has stopped working.
Several things influence your personal rate:
Plateaus around the 3 to 6 month mark are commonly reported and often resolve with a dose increase, dietary tweaks, or simply more time. It is worth tracking weekly averages rather than daily numbers, since the scale fluctuates with hydration and hormones.
If your progress feels much slower than expected, talk to your provider about whether a dose adjustment or a switch to a different GLP-1 might help. Patience matters here. These are tools that work alongside lifestyle changes, not overnight solutions, and the slow-and-steady losers tend to have the best long-term outcomes.